Hazlett, Burt & Watson’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Hazlett, Burt & Watson's OGN Position: Q3 2026 in Review
Hazlett, Burt & Watson sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 183 shares — an estimated $2K sold.
Hazlett, Burt & Watson first reported a position in OGN in Q1 2022 and held it in 18 quarters. The position peaked at $11K in Q2 2022. 264 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Hazlett, Burt & Watson reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
- Hazlett, Burt & Watson sold 183 Organon & Co shares in Q3 2026, an estimated $2K.
- Hazlett, Burt & Watson first reported a position in Organon & Co in Q1 2022 and held it in 18 quarters.
- Hazlett, Burt & Watson's Organon & Co position peaked at $11K in Q2 2022.
- 264 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.